Russell Investments Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Russell Investments Group’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-65,930	Closed	-$327K	–	3361
2021 Q1	$327K	Buy	65,930 +60,020	+1,016%	+$290K	﹤0.01%	2682
2020 Q4	$24K	Sell	5,910 -37,531	-86%	-$153K	﹤0.01%	2972
2020 Q3	$186K	Buy	+43,441	New	+$182K	﹤0.01%	2795
2018 Q3	–	Sell	-3,700	Closed	-$39K	–	3041
2018 Q2	$39K	Sell	3,700 -300	-8%	-$2.92K	﹤0.01%	2837
2018 Q1	$35K	Buy	+4,000	New	+$35.1K	﹤0.01%	2854
2017 Q4	–	Sell	-4,994	Closed	-$39K	–	3035
2017 Q3	$39K	Buy	+4,994	New	+$37.5K	﹤0.01%	2877
2017 Q2	–	Sell	-5,071	Closed	-$36K	–	3081
2017 Q1	$36K	Buy	+5,071	New	+$31.8K	﹤0.01%	2934

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Russell Investments Group's KIN Position: Q2 2021 in Review

Russell Investments Group sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 65,930 shares — an estimated $327K sold.

Russell Investments Group first reported a position in KIN in Q1 2017 and held it in 7 quarters. The position peaked at $327K in Q1 2021. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

Russell Investments Group reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
Russell Investments Group sold 65,930 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $327K.
Russell Investments Group first reported a position in Kindred Biosciences, Inc. in Q1 2017 and held it in 7 quarters.
Russell Investments Group's Kindred Biosciences, Inc. position peaked at $327K in Q1 2021.
87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.